KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Current Leases: 2017-2024

Historic Current Leases for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Dec 2024 value amounting to $9.4 million.

  • Amneal Pharmaceuticals' Current Leases fell 17.70% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year decrease of 17.70%. This contributed to the annual value of $9.4 million for FY2024, which is 2.48% up from last year.
  • According to the latest figures from FY2024, Amneal Pharmaceuticals' Current Leases is $9.4 million, which was up 2.48% from $9.2 million recorded in FY2023.
  • Amneal Pharmaceuticals' Current Leases' 5-year high stood at $9.7 million during FY2021, with a 5-year trough of $6.5 million in FY2020.
  • In the last 3 years, Amneal Pharmaceuticals' Current Leases had a median value of $9.2 million in 2023 and averaged $9.0 million.
  • Per our database at Business Quant, Amneal Pharmaceuticals' Current Leases slumped by 45.48% in 2020 and then skyrocketed by 49.61% in 2021.
  • Amneal Pharmaceuticals' Current Leases (Yearly) stood at $6.5 million in 2020, then surged by 49.61% to $9.7 million in 2021, then dropped by 14.09% to $8.3 million in 2022, then climbed by 10.65% to $9.2 million in 2023, then increased by 2.48% to $9.4 million in 2024.